Bill > HR5239

This bill, known as the Endometrial Cancer Research and Education Act of 2025, aims to expand research and public education about endometrial cancer, with a particular focus on addressing racial disparities in diagnosis and treatment. The bill recognizes that endometrial cancer is the fourth most common cancer in women, primarily affecting postmenopausal women, and notes significant disparities in incidence and mortality rates between racial groups, especially for African-American women. It directs the National Institutes of Health (NIH) to expand and coordinate research programs on endometrial cancer, communicate research findings to medical professionals, and ensure appropriate representation of African-American women in clinical trials. Additionally, the bill establishes a public education program through the Centers for Disease Control and Prevention (CDC) to develop and disseminate informational materials about the cancer, its risk factors, and available treatments, with specific materials targeted toward African-American women. The legislation authorizes $1,000,000 for NIH research activities from 2026 to 2028 and provides additional funding for the CDC's public education efforts, with the ultimate goal of improving understanding, research, and outcomes related to endometrial cancer.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/5239/all-info